ArticleFrontiers in immunology2022

Serological biomarkers predict immune-related adverse events and clinical benefit in patients with advanced gastrointestinal cancers.

Yanni Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.